Antibodies to lysophosphatidylcholine are decreased in borderline hypertension

Hypertension

Volumn 37, Issue 1, 2001, Pages 154-159

  Wu, Ruihua ^a   Lemne, Carola ^a   De Faire, Ulf ^a,b   Frostegård, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antibodies; Atherosclerosis; Hypertension, borderline; Lysophosphatidylcholine

Indexed keywords

ENDOTHELIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BORDERLINE HYPERTENSION; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYDROLYSIS; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; SMOKING;

EID: 0035156495     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.1.154     Document Type: Article

References (49)

1. Blood pressure, stroke and coronary heart disease, part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
2. Atherosclerosis: An inflammatory disease
3. Secretion of proinflammatory (Th1) cytokines in advanced human atherosclerotic plaques
4. Detection of activated T lymphocytes in the human atherosclerotic plaque
5. The immune system and hypertension
6. Do immune system changes have a role in hypertension?
7. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
8. Oxidized low-density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937
9. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
10. Biologically modified low density lipoprotein increases the adhesive properties of vascular endothelial cells
11. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis
12. Induction of T cell activation by oxidized low density lipoprotein
13. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein
14. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-γ production in lymphocytes from healthy individuals
15. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
16. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells
17. PAF and oxidized LDL induce immune activation by a common mechanism
18. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde modified LDL reduces atherogenesis
19. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits
20. Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits
21. Serum antibodies to oxidized LDL are decreased in borderline hypertension
22. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
23. Lysophosphatidylcholine induces the production of IL-1β by human monocytes
24. Lysophosphatidylcholine induces proinflammatory cytokines by a PAF-receptor dependent mechanism
25. Lysophosphatidylcholine is involved in the antigenicity of oxLDL
26. Carotid intima-media thickness and plaque in borderline hypertension
27. Dyslipoproteinemic changes in borderline hypertension
28. Structural cardiac changes in relation to 24 hour ambulatory blood pressure levels in borderline hypertension
29. Association of serum antibodies to heat shock protein 65 with borderline hypertension
30. Antibodies to endothelial cells in borderline hypertension
31. Antibodies to platelet activating factor in early cardiovascular disease
32. Suppression of collagen induced arthritis by oral administration of type II collagen: Changes in immune and arthritic responses mediated by active peripheral suppression
33. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta
34. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein
35. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation
36. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation
37. Autoantibody against oxidized LDL and progression of carotid atherosclerosis
38. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL
39. LDL oxidation in patients with severe carotid atherosclerosis: A study of in vitro and in vivo oxidation markers
40. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: A biochemical signature of an enhanced in vivo low-density lipoprotein oxidation
41. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet
42. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
43. IFN-gamma potentiated atherosclerosis in apoE knock-out mice
44. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: Role of interferon-gamma
45. Inhibition of atherosclerosis in CD4 T cell ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice
46. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity
47. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A
48. 2-glycoprotein I
49. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65